Afe A E, Shen Z J, Guo X, Zhou R, Li K. 2023. African swine fever virus interaction with host innate immune factors. Viruses, 15(6):1220.
Alonso C, Borca M, Dixon L, Revilla Y, Rodriguez F, Escribano J M, Ictv Report C. 2018. ICTV virus taxonomy profile: Asfarviridae. Journal of General Virology, 99(5):613-614.
Anderson E J, Rouphael N G, Widge A T, Jackson L A, Roberts P C, Makhene M, Chappell J D, Denison M R, Stevens L J, Pruijssers A J, McDermott A B, Flach B, Lin B C, Doria-Rose N A, O'Dell S, Schmidt S D, Corbett K S, Swanson P A, 2nd, Padilla M, Neuzil K M, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara V V, Floyd K, Suthar M S, Martinez D R, Baric R, Buchanan W, Luke C J, Phadke V K, Rostad C A, Ledgerwood J E, Graham B S, Beigel J H, m R N A S G. 2020. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. New England Journal of Medicine, 383(25): 2427-2438.
Blome S, Gabriel C, Beer M. 2014. Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation. Vaccine, 32(31):3879-3882.
Chen T, Zhu S, Wei N, Zhao Z, Niu J, Si Y, Cao S, Ye J. 2022. Protective immune responses induced by an mRNA-LNP vaccine encoding prM-E proteins against Japanese Encephalitis virus Infection. Viruses, 14(6):1121.
Deutschmann P, Forth J H, Sehl-Ewert J, Carrau T, Viaplana E, Mancera J C, Urniza A, Beer M, Blome S. 2023. Assessment of African swine fever vaccine candidate ASFV-G-∆MGF in a reversion to virulence study. NPJ Vaccines, 8(1):78.
Dixon L K, Islam M, Nash R, Reis A L. 2019. African swine fever virus evasion of host defences. Virus Research, 266:25-33.
Galindo I, Alonso C. 2017. African swine fever virus: a review. Viruses, 9(5):103.
Hua R H, Liu J, Zhang S J, Liu R Q, Zhang X F, He X J, Zhao D M, Bu Z G. 2023. Mammalian cell-line-expressed CD2v protein of African swine fever virus provides partial protection against the HLJ/18 strain in the early infection stage. Viruses, 15(7):1467.
Jiang Z, Zhu L, Cai Y, Yan J, Fan Y, Lv W, Gong S, Yin X, Yang X, Sun X, Xu Z. 2020. Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection. Veterinary Microbiology, 251:108886.
Kollnberger S D, Gutierrez-Castaneda B, Foster-Cuevas M, Corteyn A, Parkhouse R M E. 2002. Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody. Journal of Genernal Virology, 83(Pt 6):1331-1342.
Kowalczyk A, Doener F, Zanzinger K, Noth J, Baumhof P, Fotin-Mleczek M, Heidenreich R. 2016. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine, 34(33):3882-3893.
Lokhandwala S, Waghela S D, Bray J, Sangewar N, Charendoff C, Martin C L, Hassan W S, Koynarski T, Gabbert L, Burrage T G, Brake D, Neilan J, Mwangi W. 2017. Adenovirus-vectored novel African swine fever virus antigens elicit robust immune responses in swine. PLoS One, 12(5):e0177007.
Lopez E, van Heerden J, Bosch-Camos L, Accensi F, Navas M J, Lopez-Monteagudo P, Argilaguet J, Gallardo C, Pina-Pedrero S, Salas M L, Salt J, Rodriguez F. 2020. Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in cross-protection. Viruses, 12(12):1474.
Lv C, Yang J, Zhao L, Wu C, Kang C, Zhang Q, Sun X, Chen X, Zou Z, Jin M. 2022. Infection characteristics and transcriptomics of African swine fever virus in bama minipigs. Microbiology Spectrum, 10(6):e0383422.
Miao L, Zhang Y, Huang L. 2021. mRNA vaccine for cancer immunotherapy. Molecular Cancer, 20(1), 41.
Mulligan M J, Lyke K E, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson K A, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi P Y, Tureci O, Tompkins K R, Walsh E E, Frenck R, Falsey A R, Dormitzer P R, Gruber W C, Sahin U, Jansen K U. 2021. Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 590(7844):E26.
Reis A L, Parkhouse R M E, Penedos A R, Martins C, Leitao A. 2007. Systematic analysis of longitudinal serological responses of pigs infected experimentally with African swine fever virus. Journal of General Virology, 88(Pt 9):2426-2434.
Schnee M, Vogel A B, Voss D, Petsch B, Baumhof P, Kramps T, Stitz L. 2016. An mRNA vaccine encoding Rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Neglected Tropical Diseases, 10(6):e0004746.
Tran X H, Phuong L T T, Huy N Q, Thuy D T, Nguyen V D, Quang P H, Ngon Q V, Rai A, Gay C G, Gladue D P, Borca M V. 2022. Evaluation of the safety profile of the ASFV vaccine candidate ASFV-G-ΔI177L. Viruses, 14(5):896.
Veiga N, Goldsmith M, Granot Y, Rosenblum D, Dammes N, Kedmi R, Ramishetti S, Peer D. 2018. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nature Communications, 9(1):4493.
Wang Q, Zhou L, Wang J, Su D, Li D, Du Y, Yang G, Zhang G, Chu B. 2022. African swine fever virus K205R induces ER stress and consequently activates autophagy and the NF-kappaB signaling pathway. Viruses, 14(2):394.
Wang Y, Zhang Z, Luo J, Han X, Wei Y, Wei X. 2021. mRNA vaccine: a potential therapeutic strategy. Molecular Cancer, 20(1):33.
Wu X, Xiao L, Peng B, Wang Y, Yang Z, Yao X, Hu L, Lin X. 2016. Prokaryotic expression, purification and antigenicity analysis of African swine fever virus pK205R protein. Polish Journal of Veterinary Sciences, 19(1):41-48.
Zhou X, Li N, Luo Y, Liu Y, Miao F, Chen T, Zhang S, Cao P, Li X, Tian K, Qiu H J, Hu R. 2018. Emergence of African Swine Fever in China, 2018. Transboundary and Emerging Diseases, 65(6):1482-1484.
|